Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Multiple Sclerosis

  Free Subscription


1 Acta Neurol Scand
1 Ann Neurol
1 Arch Phys Med Rehabil
1 BMC Neurol
1 J Neuroimmunol
1 J Neurol
1 J Neurol Sci
5 Mult Scler
1 Nat Rev Neurol
1 Neurologia
1 Neurologia (Engl Ed)
4 Neurology
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Rev Neurol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neurol Scand

  1. ZHUKOVSKY C, Herman S, Wiberg A, Cunningham JL, et al
    Urokinase, CX3CL1, CCL2, TRAIL and IL-18 induced by interferon-beta treatment.
    Acta Neurol Scand. 2021;143:602-607.
    PubMed         Abstract available

    Ann Neurol

  2. OECHTERING J, Schaedelin S, Benkert P, Muller S, et al
    Intrathecal Immunoglobulin M synthesis is an independent biomarker for higher disease activity and severity in multiple sclerosis.
    Ann Neurol. 2021 May 31. doi: 10.1002/ana.26137.
    PubMed         Abstract available

    Arch Phys Med Rehabil

  3. VAN SCHOOTEN KS, Taylor ME, Close JC, Davis JC, et al
    Arch Phys Med Rehabil. 2020 Nov 27. pii: S0003-9993(20)31256.
    PubMed         Abstract available

    BMC Neurol

  4. BOTCHORISHVILI N, Shiukashvili N, Mikeladze N, Dzagnidze A, et al
    Validity and reliability of the Georgian-language brief international cognitive assessment for multiple sclerosis (BICAMS).
    BMC Neurol. 2021;21:218.
    PubMed         Abstract available

    J Neuroimmunol

  5. NIINO M, Fukazawa T, Miyazaki Y, Ura S, et al
    Seasonal fluctuations in serum levels of vitamin D in Japanese patients with multiple sclerosis.
    J Neuroimmunol. 2021;357:577624.
    PubMed         Abstract available

    J Neurol

  6. HAVLA J, Schultz Y, Zimmermann H, Hohlfeld R, et al
    First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.
    J Neurol. 2021 Jun 11. pii: 10.1007/s00415-021-10648.

    J Neurol Sci

  7. FUJIMORI J, Nakashima I
    Serum neurofilament light is a sensitive biomarker that reflects grey matter volume in Japanese patients with multiple sclerosis.
    J Neurol Sci. 2021;427:117528.
    PubMed         Abstract available

    Mult Scler

  8. GARJANI A, Hunter R, Law GR, Middleton RM, et al
    Mental health of people with multiple sclerosis during the COVID-19 outbreak: A prospective cohort and cross-sectional case-control study of the UK MS Register.
    Mult Scler. 2021 Jun 3:13524585211020435. doi: 10.1177/13524585211020435.
    PubMed         Abstract available

  9. VAN DAM M, Hulst HE, Schoonheim MM
    Coupling structure and function in early MS: How a less diverse repertoire of brain function could lead to clinical progression.
    Mult Scler. 2021;27:491-493.

  10. KALINOWSKI A, Cutter G, Bozinov N, Hinman JA, et al
    The timed 25-foot walk in a large cohort of multiple sclerosis patients.
    Mult Scler. 2021 Jun 8:13524585211017013. doi: 10.1177/13524585211017013.
    PubMed         Abstract available

  11. SADOVNICK AD, Yee IM, Criscuoli M, DeLuca GC, et al
    Genes and environment in multiple sclerosis: Impact of temporal changes in the sex ratio on recurrence risks.
    Mult Scler. 2021 Jun 8:13524585211020221. doi: 10.1177/13524585211020221.
    PubMed         Abstract available

  12. CORTESE R, Battaglini M, Parodi F, Stromillo ML, et al
    Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course.
    Mult Scler. 2021 Jun 8:13524585211019650. doi: 10.1177/13524585211019650.
    PubMed         Abstract available

    Nat Rev Neurol

  13. CENCIONI MT, Mattoscio M, Magliozzi R, Bar-Or A, et al
    B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies.
    Nat Rev Neurol. 2021 Jun 1. pii: 10.1038/s41582-021-00498.
    PubMed         Abstract available


  14. ZHANG GX, Zhang WT, Gao SS, Zhao RZ, et al
    Sleep disorders in patients with multiple sclerosis in Spain.
    Neurologia. 2021 Jun 5. pii: S0213-4853(21)00080.
    PubMed         Abstract available

    Neurologia (Engl Ed)

  15. PINAR MORALES R, Ramirez Rivas MA, Barrero Hernandez FJ
    SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis.
    Neurologia (Engl Ed). 2021 Jun 1. pii: S2173-5808(21)00079.
    PubMed         Abstract available


  16. MAGGI P, Kuhle J, Schadelin S, van der Meer F, et al
    Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012326.
    PubMed         Abstract available

  17. CAMPBELL CREE BA, Arnold DL, Chataway J, Chitnis T, et al
    Secondary Progressive Multiple Sclerosis: New Insights.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012323.
    PubMed         Abstract available

  18. PREZIOSA P, Schoonheim MM
    Ongoing Axonal Injury in Chronic Active Lesions in Multiple Sclerosis: In-Vivo Quantification Using Serum Neurofilament.
    Neurology. 2021 Jun 4. pii: WNL.0000000000012331.

  19. HUISKAMP M, Eijlers AJC, Broeders TAA, Pasteuning J, et al
    Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis.
    Neurology. 2021 Jun 7. pii: WNL.0000000000012341.
    PubMed         Abstract available

    PLoS One

  20. KOENIG KA, Beall EB, Sakaie KE, Ontaneda D, et al
    Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis.
    PLoS One. 2021;16:e0251338.
    PubMed         Abstract available

  21. CARTER B, Hayes C, Smith A, Pennington A, et al
    A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease.
    PLoS One. 2021;16:e0251484.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  22. PATERGNANI S, Bonora M, Ingusci S, Previati M, et al
    Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available

    Rev Neurol

  23. FERNANDEZ O, Montalban X, Aladro Y, Alonso A, et al
    13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (I).
    Rev Neurol. 2021;72:397-406.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.